View Older Stories View More Recent Stories

Feb 14, 2023 08:05AM Savara Announces New Leadership Appointments
Jan 20, 2023 08:05AM Savara Announces New Employment Inducement Grant
Nov 22, 2022 04:05PM Savara Announces New Employment Inducement Grant
Nov 10, 2022 04:05PM Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
Nov 9, 2022 04:05PM Savara to Participate in Three Upcoming Investor Conferences
Sep 14, 2022 04:05PM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Sep 6, 2022 04:05PM Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
Sep 1, 2022 08:05AM Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
Aug 26, 2022 08:05AM Savara (SVRA) Announces Chief Medical Officer Resignation
Aug 26, 2022 08:05AM Savara Announces Resignation of Chief Medical Officer
Aug 25, 2022 08:05AM Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Aug 11, 2022 04:05PM Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
Jul 11, 2022 08:05AM Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
Jun 16, 2022 08:05AM Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
Jun 1, 2022 04:05PM Savara to Present at Jefferies Healthcare Conference
May 17, 2022 04:05PM Savara to Present at H.C. Wainwright Global Investment Conference
May 11, 2022 04:05PM Savara Reports First Quarter 2022 Financial Results and Provides Business Update
Apr 26, 2022 04:05PM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Apr 22, 2022 08:05AM Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
Mar 30, 2022 04:05PM Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update
Mar 16, 2022 04:05PM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Mar 9, 2022 08:05AM Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Jan 4, 2022 08:05AM Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Dec 2, 2021 04:05PM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Nov 15, 2021 08:05AM Savara to Participate in Two Upcoming Investor Healthcare Conferences
Nov 12, 2021 08:05AM Savara Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 10, 2021 08:05AM Savara to Present at the Jefferies London Healthcare Conference
Oct 7, 2021 04:05PM Savara to Present at the Inaugural Piper Sandler Lung Day
Sep 7, 2021 08:05AM Savara to Participate in Two Upcoming Investor Healthcare Conferences
Sep 3, 2021 08:05AM Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 20, 2021 08:05AM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Aug 12, 2021 04:05PM Savara Reports Second Quarter 2021 Financial Results and Provides Business Update
Jun 30, 2021 10:47AM Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial
May 26, 2021 08:05AM Savara to Present at the Jefferies Virtual Healthcare Conference
May 17, 2021 08:05AM Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit
May 14, 2021 08:05AM Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
May 13, 2021 04:05PM Savara Reports First Quarter 2021 Financial Results and Provides Business Update
Mar 15, 2021 09:32AM Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option
Mar 11, 2021 08:58AM Savara (SVRA) Prices Public Offering of Common Stock, Warrants
Mar 11, 2021 08:57AM Savara Announces Pricing of Public Offering of Common Stock
Mar 10, 2021 04:49PM Savara (SVRA) Announces Proposed Public Offering of Common Stock
Mar 10, 2021 04:49PM Savara Announces Proposed Public Offering of Common Stock
Dec 10, 2020 08:11AM Savara (SVRA) Provides Pipeline and Business Update
Dec 10, 2020 08:05AM Savara Provides Pipeline and Business Update
Nov 24, 2020 04:15PM Savara Announces Participation in Fireside Chats at Two Upcoming Virtual Investor Healthcare Conferences
Nov 11, 2020 04:05PM Savara to Present at the Jefferies Virtual London Healthcare Conference
Nov 5, 2020 04:20PM Savara Reports Third Quarter 2020 Financial Results and Provides Business Update
Sep 11, 2020 08:05AM Savara Announces Senior Management Changes
Sep 9, 2020 04:05PM Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually
Sep 8, 2020 08:10AM Savara (SVRA) Announces NEJM Publication of IMPALA Study Results
View More Recent Stories View Older Stories